The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster

Anesthesia and Analgesia

Volumn 109, Issue 5, 2009, Pages 1651-1655

  Ji, Genlin ^a   Niu, Jiyuan ^a   Shi, Yuxiang ^a   Hou, Lichao ^a   Lu, Yan ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANALGESIC AGENT; ANTIVIRUS AGENT; BUPIVACAINE; DICLOFENAC; LOCAL ANESTHETIC AGENT; METHYLPREDNISOLONE ACETATE; NARCOTIC AGENT; STEROID; DRUG DERIVATIVE; METHYLPREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ADULT; AGED; ALLODYNIA; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; FEMALE; HERPES ZOSTER; HUMAN; INJECTION; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SPINAL ANESTHESIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED; NERVE BLOCK; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; TIME; VIROLOGY;

ACUTE DISEASE; ACYCLOVIR; ADMINISTRATION, ORAL; AGED; ANALGESICS; ANESTHETICS, LOCAL; ANTIVIRAL AGENTS; BUPIVACAINE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HERPES ZOSTER; HUMANS; INJECTIONS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NERVE BLOCK; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350736262     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181b79075     Document Type: Article

References (28)

1. Galluzzi KE. Management strategies for herpes zoster and postherpetic neuralgia. J Am Osteopath Assoc 2007;107:S8-S13
2. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-2284
3. Pavan-Langston D. Herpes zoster antivirals and pain management. Ophthalmology 2008;115:S13-S20
4. Dworkin RH. Prevention of postherpetic neuralgia. Lancet 1999;353:1636-1637
5. Kimberlin DW, Whitley RJ. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med 2007;356:1338-1343
6. Tyring SK. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol 2007;57:S136-S142
7. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan- Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44(suppl 1):S1-S26
8. Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain 2008;9:S3-S9
9. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain 2000;16:S90-S100
10. Johnson R. Herpes zoster-predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother 2001;47(suppl T1):1-8
11. Woolf CJ. A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs 1994;47(suppl 5):1-9; discussion 46-47
12. Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities. Can J Anaesth 2001;48:1000-1010
13. Johnson RW. Consequences and management of pain in herpes zoster. J Infect Dis 2002;186(suppl 1):S83-S90
14. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004;62:1545-1551
15. Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg Anesth Pain Med 2004;29:454-461
16. Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, Asai M, Matsuki A. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 2000;343:1514-1519
17. Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy-a systematic review and metaanalysis of randomized trials. Br J Anaesth 2006;96:418-426
18. Hardy D. Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia. Can J Anaesth 2005;52:186-190
19. Naja ZM, Maaliki H, Al-Tannir MA, El-Rajab M, Ziade F, Zeidan A. Repetitive paravertebral nerve block using a catheter technique for pain relief in post-herpetic neuralgia. Br J Anaesth 2006;96:381-383
20. Rosenak SS. Paravertebral procaine block for the treatment of herpes zoster. NY State J Med 1956;56:2684-2687
21. Johnson LR, Rocco AG, Ferrante FM. Continuous subpleuralparavertebral block in acute thoracic herpes zoster. Anesth Analg 1988;67:1105-1108
22. Yanagida H, Suwa K, Corssen G. No prophylactic effect of early sympathetic blockade on postherpetic neuralgia. Anesthesiology 1987;66:73-76
23. van Wijck AJ, Opstelten W, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, Verheij TJ. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006;367:219-224
24. Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, Paoletti F, Girardis M, Lugano M, Del Sindaco F. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000;44:910-918
25. Esmann V, Geil JP, Kroon S, Fogh H, Peterslund NA, Petersen CS, Ronne-Rasmussen JO, Danielsen L. Prednisolone does not prevent post-herpetic neuralgia. Lancet 1987;2:126-129
26. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993;18:277-282
27. Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 1999;24:287-293
28. Abram SE. Intrathecal steroid injection for postherpetic neuralgia: what are the risks? Reg Anesth Pain Med 1999;24:283-285